KERRI ELLINGER: Open Payments
NPI 1376732917 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$499 in 18 payments from 8 companies in 2025. Trend: 2023 $706 · 2024 $450 · 2025 $499
Food & beverage: $499
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $137 |
| Sumitomo Pharma America, Inc. | 6 | $125 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $60 |
| Organon LLC | 2 | $58 |
| Exeltis, USA Inc. | 1 | $37 |
| Evofem Biosciences, Inc. | 2 | $34 |
| Astellas Pharma US Inc | 1 | $28 |
| Exact Sciences Corporation | 1 | $21 |
Products named: EVENITY, MYFEMBREE, Mirena, NEXPLANON, SLYND, Phexxi, Veozah, Cologuard Collection Kit.
Industry payments across MD — which companies pay providers there.
